{
    "organizations": [],
    "uuid": "08cf54dbf61d3ca86633f39c654ac4db7bc0a9e9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-boehringer-ingelheim-says-praxbind/brief-boehringer-ingelheim-says-praxbind-now-stocked-in-3200-hospitals-in-all-50-u-s-states-idUSFWN1SB0Q6",
    "ord_in_thread": 0,
    "title": "BRIEF-Boehringer Ingelheim Says Praxbind Now Stocked In 3,200 Hospitals In All 50 U.S. States",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 4 (Reuters) - Boehringer Ingelheim:\n* BOEHRINGER INGELHEIM SAYS PRAXBIND (IDARUCIZUMAB), A SPECIFIC REVERSAL AGENT FOR PRADAXA, IS NOW STOCKED IN 3,200 HOSPITALS IN ALL 50 U.S. STATES Source text for Eikon:\n ",
    "published": "2018-05-04T20:28:00.000+03:00",
    "crawled": "2018-05-05T12:21:49.015+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "boehringer",
        "ingelheim",
        "boehringer",
        "ingelheim",
        "say",
        "praxbind",
        "idarucizumab",
        "specific",
        "reversal",
        "agent",
        "pradaxa",
        "stocked",
        "hospital",
        "state",
        "source",
        "text",
        "eikon"
    ]
}